Baumer

Baumer EBIT Growth

The Year-over-Year EBIT Growth of Baumer (BALM4.SA) as of Nov 15, 2026 is 63.64 %. In the previous year, Year-over-Year EBIT Growth was 23.03 % — a change of 176.33% (higher).

EBIT Growth

63.64 %

YoY

176.33%

Last updated:

Year-over-Year EBIT Growth of Baumer is 2024 63.64 % . Year-over-Year EBIT Growth of Baumer was 2023 23.03 % . It decreases by 176.33% higher compared to the previous year.

The Baumer EBIT Growth history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBIT Growth
Date
EBIT Growth
Jan 1, 2017
-64.14 BRL
Jan 1, 2018
62.46 BRL
Jan 1, 2019
69.93 BRL
Jan 1, 2020
86.01 BRL
Jan 1, 2021
-28.28 BRL
Jan 1, 2022
46.15 BRL
Jan 1, 2023
23.03 BRL
Jan 1, 2024
63.64 BRL
The Baumer EBIT Growth history
YEAREBIT GrowthYoY
63.64 %+176.33%
23.03 %-50.11%
46.15 %-263.22%
-28.28 %-132.88%
86.01 %+23.00%
69.93 %+11.95%
62.46 %-197.38%
-64.14 %+82.01%
-35.24 %+107.35%
-17.00 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Baumer Stock analysis

What does Baumer do? Baumer SA generates revenue through the sale of medical equipment and solutions across its four business units. The Orthopedic unit produces and sells orthopedic implants and instruments, while the Hospital unit manufactures equipment for hospitals and industries including pharmaceutical, chemical, cosmetic, and food sectors. The Genius unit focuses on biomaterials, and the Brown unit supplies laundry equipment for hospitals, industrial, and hotel settings. The company's subsidiaries, Hospitalar Sul Ltda and Waldsea Investment SA, support its operations as of December 31, 2011. The primary buyers of Baumer SA's products include hospitals, pharmaceutical companies, chemical manufacturers, cosmetic firms, and food industry businesses. Additionally, industrial and hotel sectors purchase the laundry equipment from the Brown unit. The company's technical assistance services for medical apparatus also contribute to its revenue stream. Baumer SA's business model relies on direct sales of its specialized equipment and solutions to healthcare and industrial clients. The firm's product portfolio spans orthopedic care, hospital infrastructure, biomaterials, and laundry systems, catering to both medical and non-medical industrial applications. This diversified approach allows the company to serve multiple segments within the health and industrial markets. Baumer is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Baumer stock

Year-over-Year EBIT Growth of Baumer is 63.64 % in 2024.

On Eulerpool you can find the complete historical development of Year-over-Year EBIT Growth Baumer since 2006 – with annual values, charts, and detailed analysis.

EBIT growth measures the percentage change in operating earnings. It shows whether a company's core operations are becoming more profitable.

To evaluate Year-over-Year EBIT Growth's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Year-over-Year EBIT Growth.

Year-over-Year EBIT Growth's is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Year-over-Year EBIT Growth's Baumer historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Growth — Baumer

All Key Metrics — Baumer